[Ovarian epithelial dysplasia: Description of a dysplasia scoring scheme]

Ann Pathol. 2011 Feb;31(1):3-10. doi: 10.1016/j.annpat.2010.10.008. Epub 2011 Jan 26.
[Article in French]

Abstract

Introduction: Precancerous ovarian epithelial dysplasia was first described after prophylactic oophorectomy (OP) for genetic risk (BRCA mutation) or because of a strong family history of ovarian and/or breast cancer. The objective of this study was to describe histopathological features of ovarian dysplasia and to propose a dysplasia scoring sheme with a cut-off.

Patients and method: One hundred and twenty-five bilateral oophorectomies (genetic predisposition: n=35 and control group: n=90) were reviewed by two pathologists blinded to clinical data. Eleven epithelial cytological and architectural features were studied and an ovarian dysplasia score was defined to compare the degree of ovarian epithelial abnormalities between the two groups.

Results: Mean ovarian dysplasia score was significantly higher in prophylactic oophorectomy group than in control group (9.0 versus 3.5, P<0.001). Dysplasia was more severe in OP with BRCA mutation than in OP without (11.6 in BRCA 1; 7.6 in BCRA 2; 7.1 in family history). The cut off for dysplasia was 8 with a sensitivity of 60% and a specificity of 93.3%.

Conclusion: The increased dysplasia score in OP and the gradation in dysplastic severity in OP with proven BRCA mutations may suggest that ovarian dysplasia could be a pre-malignant non invasive histopathological lesion. The 11 cytological and architectural features in the dysplasia scoring sheme could be a useful tool to study ovarian dysplasia.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adult
  • Breast Neoplasms / genetics
  • Case-Control Studies
  • Cell Division
  • Cell Nucleus / ultrastructure
  • Chromatin / ultrastructure
  • Epithelial Cells / ultrastructure*
  • Female
  • Genes, BRCA1
  • Genes, BRCA2
  • Genetic Predisposition to Disease
  • Humans
  • Middle Aged
  • Neoplastic Syndromes, Hereditary / pathology*
  • Ovarian Diseases / genetics
  • Ovarian Diseases / pathology*
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / pathology*
  • Ovarian Neoplasms / prevention & control
  • Ovariectomy
  • Ovary / pathology*
  • Precancerous Conditions / genetics
  • Precancerous Conditions / pathology*
  • ROC Curve
  • Severity of Illness Index*
  • Single-Blind Method
  • Stromal Cells / ultrastructure

Substances

  • Chromatin